RESUMO
INTRODUCTION: Catheter ablation for atrial fibrillation (AF) is associated with prolonged fluoroscopy times. We prospectively evaluated the use of the LocaLisa three-dimensional nonfluoroscopic catheter imaging system with the aim of reducing fluoroscopy times during pulmonary vein (PV) disconnection. METHODS AND RESULTS: Fifty-two patients with AF (47 men and 5 women, mean age 53 +/- 9 years) underwent disconnection of all four PVs guided by a circumferential mapping catheter. The LocaLisa navigation system was used for real-time three-dimensional nonfluoroscopic imaging of the circumferential mapping catheter and ablation catheter electrodes in 26 patients. Procedural parameters were compared with those of a control group consisting of 26 patients in whom only standard fluoroscopy was used. PV disconnection was performed similarly in both groups by circumferential ablation around the ostia, with the endpoint of disconnecting left atrium to PV breakthroughs. The cumulative duration of radiofrequency (RF) energy delivery, procedural time, and fluoroscopy time required for PV disconnection were compared. Successful disconnection was achieved in all PVs, without acute complications. There was no significant difference in cumulative RF energy delivery: 34.8 +/- 11.4 minutes for the nonfluoroscopic imaging group versus 38.2 +/- 10.5 minutes for the control group. The fluoroscopy time required for disconnection of all four PVs was significantly lower in the LocaLisa group than in the control group: 8.4 +/- 4.3 minutes versus 23.7 +/- 9.7 minutes (P < 0.0001). There also was a significant difference in the mean time taken for PV disconnection: 46.5 +/- 12.0 minutes for the nonfluoroscopic imaging group versus 66.3 +/- 18.9 minutes for the control group (P < 0.0001). CONCLUSION: By allowing continuous three-dimensional monitoring of ablation and mapping catheter position and orientation, the LocaLisa nonfluoroscopic imaging system significantly reduces fluoroscopy and PV disconnection times.
Assuntos
Fibrilação Atrial/cirurgia , Mapeamento Potencial de Superfície Corporal/instrumentação , Mapeamento Potencial de Superfície Corporal/métodos , Ablação por Cateter/métodos , Imageamento Tridimensional/métodos , Veias Pulmonares/cirurgia , Cirurgia Assistida por Computador/métodos , Fibrilação Atrial/diagnóstico por imagem , Ablação por Cateter/instrumentação , Análise de Falha de Equipamento , Feminino , Fluoroscopia/métodos , Humanos , Imageamento Tridimensional/instrumentação , Cuidados Intraoperatórios/métodos , Masculino , Pessoa de Meia-Idade , Veias Pulmonares/diagnóstico por imagem , Proteção Radiológica/métodos , Cirurgia Assistida por Computador/instrumentação , Resultado do TratamentoRESUMO
RF catheter ablation of paroxysmal atrial fibrillation (PAF) is associated with prolonged fluoroscopy. The procedural duration and fluoroscopic exposure to patients and medical staff were recorded and compared among 43 ablation procedures for PAF, 20 for common atrial flutter, and 16 for accessory pathways. Patient radiation exposure was measured by dosimeters placed over the xyphoid, while that of physicians and nurses was measured by dosimeters placed outside and inside the lead apron. The mean fluoroscopy time was 57 +/- 30 minutes for PAF, 20 +/- 10 minutes for common flutter, and 22 +/- 21 minutes for accessory pathway ablation. The patient median radiation exposure was 1110 microSv for PAF, compared with 500 microSv for common flutter and 560 microSv for accessory pathway ablation (P < 0.01). The median radiation exposure to physician and nurse inside the lead apron were, respectively, 2 microSv and 3 microSv for PAF, 1 microSv and 2 microSv for common flutter, and < 0.5 microSv and 3 microSv for accessory pathway ablations. RF catheter ablation for PAF was associated with prolonged fluoroscopy times and a twofold higher radiation exposure to the patient and physician compared with other ablation procedures. Assuming 300 procedures/year, radiation exposure to the medical staff was below the upper recommended annual dose limit.